Although there are several conflicting data regarding the role of NR4A2 and OPRL1 in cancer, our results are in accordance with current observations: NR4A2 can trans-activate Foxp3, involved in the differentiation, maintenance, and function of regulatory T cells, and plays a significant role in cancer cell development and survival [51,52,53]. This evidence concerns the gene NR4A2 and cancer.